1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile … – Marketwire (press release)

March 18, 2013HLA Typingadmin

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile ...
Marketwire (press release)
In February 2013, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCoreĀ® HLA typing kits. The Quidel Molecular Direct C. difficile Assay is Quidel's first assay with a streamlined stool processing procedure. Quidel also ...

and more »

Post navigation

← Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile … – MarketWatch (press release) Quidel And Life Technologies Receive FDA Clearance For Clostridium Difficile … – Daily Markets (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos